Chris Miller

I serve as the Vice President of Biometrics for Respiratory & Immunology, in Late-Stage Research & Development. I lead a global team of world-class scientists encompassing statistics, statistical programming, and information science. I am a member of Early- and Late-Stage R&D governing bodies at AstraZeneca, ensuring rigor in design, interpretation, and assessment of the probability of success of our clinical programmes.

Our department is accountable for the quantitative elements of the design, delivery, and interpretation of clinical trials; regulatory submissions and interactions; scientific exchange; and reimbursement support. We strive to be greater than the sum of our parts through collaboration and knowledge-sharing, providing insights across the enterprise to accelerate drug development.

I joined AstraZeneca in 1993 and, since then, have been dedicated to the development of innovative medicines to millions of patients who need them. I have held several different positions at AstraZeneca, which have enabled me to broaden and deepen my understanding of drug development and continue to hone my leadership and collaboration skills.

I am proud of the role I have played in the professional development of our staff – through recruitment, training, coaching, and mentoring. I believe that the next generation of drug developers can be even more successful and efficient than the current one.